CITADEL ADVISORS LLC 13D/13G Filings for Ikena Oncology, Inc. (IKNA)

CITADEL ADVISORS LLC 13D and 13G filings for Ikena Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
4:57 pm
Sale		2023-12-3113GIkena Oncology, Inc.
IKNA		CITADEL ADVISORS LLC178,177
0.400%		-1,976,957decrease
(-91.73%)		Filing
2023-02-14
08:02 am
Purchase		2022-12-3113GIkena Oncology, Inc.
IKNA		CITADEL ADVISORS LLC2,155,134
5.900%		26,926increase
(+1.27%)		Filing
2022-02-14
06:12 am
Purchase		2021-12-3113GIkena Oncology, Inc.
IKNA		CITADEL ADVISORS LLC2,128,208
5.900%		73,255increase
(+3.56%)		Filing
2021-04-09
4:57 pm
Purchase		2021-03-3013GIkena Oncology, Inc.
IKNA		CITADEL ADVISORS LLC2,054,953
6.600%		2,054,953increase
(New Position)		Filing